Showing results (81-90 of 515) with videos related to

Sort By:
Pageof 52
Oncology (Williston Park, N.Y.)|August 9, 2012
Hypofractionated radiation therapy for prostate cancer: risks and potential benefits in a fiscally conservative health care systemSanjay Aneja, Ramya R Pratiwadi, James B Yu
Journal of Surgical Oncology|December 4, 2023
2023 Radiation oncology highlightsKilian E Salerno, Prajnan Das, James B Yu
International Journal of Radiation Oncology, Biology, Physics|July 3, 2010
A new formula for prostate cancer lymph node riskJames B Yu, Danil V Makarov, Cary Gross
Seminars in Radiation Oncology|December 18, 2016
Emerging Technologies and Techniques in Radiation TherapyWilliam J Magnuson, Amandeep Mahal, James B Yu
Journal of the National Cancer Institute. Monographs|July 5, 2022
Health Economics Research in Cancer Treatment: Current Challenges and Future DirectionsJames B Yu, Deborah Schrag, K Robin Yabroff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancerJohn T Wei, Rodney L Dunn, Howard M Sandler, et al.
CA: a Cancer Journal for Clinicians|February 22, 2017
Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manualMark K Buyyounouski, Peter L Choyke, Jesse K McKenney, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 2011
Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablationAaron Sabolch, Felix Y Feng, Stephanie Daignault-Newton, et al.
Urology|March 1, 2008
Impact of common iliac nodal treatment on radiation outcomes in localized prostate cancerDaniel E Soto, Scott Glaser, Rebecca H Roberts, et al.
Pageof 52